You can buy or sell STAAR and other stocks, options, ETFs, and crypto commission-free!
STAAR Surgical Co. engages in the development, manufacture, production, market, and trade of implantable lenses for the eye and delivery systems. It specializes in refractive and cataract solutions. Read More Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Monrovia, CA.
52 Week High
52 Week Low
Simply Wall StMar 20
STAAR Surgical’s (NASDAQ:STAA) Wonderful 402% Share Price Increase Shows How Capitalism Can Build Wealth
We think that it’s fair to say that the possibility of finding fantastic multi-year winners is what motivates many investors. You won’t get it right every time, but when you do, the returns can be truly splendid. One bright shining star stock has been STAAR Surgical Company (NASDAQ:STAA), which is 402% higher than three years ago. Also pleasing for shareholders was the 14% gain in the last three months. But this could be related to the strong market, which is up 15% in the last three months. See our latest...
Stock Price, News, & Analysis for STAAR Surgical
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye.
The Motley FoolFeb 21
Staar Surgical Co (STAA) Q4 2018 Earnings Conference Call Transcript
Staar Surgical Co (NASDAQ:STAA) Q4 2018 Earnings Conference Call , 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, ladies and gentlemen, thank you for standing by. Welcome to the STAAR Surgical Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions) This call is being recorded today, Thursday, February 21, 2019. At this time, I would like to turn the conference call over to Mr. Brian Moore wit...
Expected May 1, After Hours